CHLORAMPHENICOL FISIOPHARMA 1G İsrail - İngilizce - Ministry of Health

chloramphenicol fisiopharma 1g

propharm ltd - chloramphenicol - powder for solution for injection - chloramphenicol 1 g - chloramphenicol - chloramphenicol is active against several bacteria in the following infections:- typhoid fever and salmonellosis (salmonella typhi);- bacterial meningitis (haemophilus influenzae, neisseria meningitidis);- rickettiosis (rickettsia);- brucellosis (brucella);- psittacosis (chlamydophila psittaci);- lymphogranuloma venereum (lymphogranuloma-psittacosis);- urinary infection caused by gram-negative bacteria;- infections caused by anaerobic bacteria (cocci gram-positive cocci, clostridium).and is indicated when oral administration is contraindicated or not feasible due to vomiting, diarrhea or severe sepsis .

MYOCHOLINE-GLENWOOD 25 MG İsrail - İngilizce - Ministry of Health

myocholine-glenwood 25 mg

propharm ltd - bethanechol chloride - tablets - bethanechol chloride 25 mg - bethanechol - myocholine glenwood is indicated in cases of postoperative urinary retention due to atony of the bladder in adults in diseases in which a stimulation of the bladder muscle is needed.

CASPOFUNGIN WOCKHARDT 50 MG İsrail - İngilizce - Ministry of Health

caspofungin wockhardt 50 mg

propharm ltd - caspofungin as acetate - powder for concentrate for solution for infusion - caspofungin as acetate 50 mg - caspofungin - caspofungin wockhrdt is indicated in adults and pediatric patients (3 months and older) for:- empirical therapy for presumed fungal infections in febrile, neutropenic patients.- treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. caspofungin has not been studied in endocarditis, ostemyelitis, and meningitis due to candida.- treatment of esophageal candidiasis.- treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin b, lipid formulations of amphotericin b, and/or itraconazole). caspofungin has not been studied as initial therapy for invasive aspergillosis